Skip to main content
. 2006 Mar 1;26(9):2443–2448. doi: 10.1523/JNEUROSCI.3294-05.2006

Table 1.

Average parameters and results in the four series of experiments

Series 1 (n = 20) 2 (n = 14) 3 (n = 16) 4 (n = 19) Total (n = 69) Exp versus Con Wilcoxon T Series K–W H
Shock (mA)
    Exp 5.5 6.2 4.8 5.5 5.5 723.0NS 1.69NS
    Con 5.5 5.0 5.0 5.2 5.0
Criterion (mm)
    Exp 0.62 0.62 0.62 0.62 0.62 2.0NS 1.29NS
    Con 0.62 0.62 0.62 0.62 0.62
First response (s)
    Exp 28 28 40 41 33 10.61*
Time above criterion (%)
    Pre
        Exp 1 5 4 2 3 1145.5NS 2.56NS
        Con 2 5 3 2 2
    Phase I training
        Exp 92 92 95 94 94 276.5** 2.38NS
        Con 66 70 80 69 70
    Phase I extinction
        Exp 31 29 25 23 29 847.5* 3.47NS
        Con 17 22 26 14 18
    Phase II training
        Exp 92 94 94 96 94 795.5* 3.02NS
        Con 75 84 94 95 88
    Phase II extinction
        Exp 22 19 14 31 19 692.0** 1.65NS
        Con 11 12 13 13 12
Spontaneous contractions (s)
    Pre
        Exp 34 108 101 29 65 1081.5NS 6.53NS
        Con 60 99 78 39 63
    First extinction
        Exp 127 168 106 77 106 875.0* 7.69NS
        Con 84 78 107 69 79
    Last extinction
        Exp 65 104 60 70 69 1015.5NS 4.99NS
        Con 62 82 57 72 71
Baseline shift (mm)
    Pre
        Exp 0 0 0 0 0 812.0NS 4.07NS
        Con 0 0 0 0 0
    First extinction
        Exp 1.41 0.78 0.78 0.94 0.62 842.5NS 1.96NS
        Con 0.94 0.31 1.09 0.62 0.62
    Last extinction
        Exp 1.72 0.31 0.62 1.56 0.94 604.5* 1.06NS
        Con 0.47 −0.16 0.16 0.62 0.31

Median values of the parameters and results in the four series of experiments (see Materials and Methods) and overall are shown. The experimental and control animals were compared by Wilcoxon’s signed-ranks tests (T), and the four series of experiments were compared by Kruskal–Wallis ANOVAs (K–W H). Exp, Experimental; Con, control; Pre, pretest period.

*p < 0.05;

**p < 0.01;

NS, not significant.

HHS Vulnerability Disclosure